MOUNTAIN VIEW, Calif., May 26, 2011 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM) announced the pricing of its underwritten public offering of 5,500,000 shares of its common stock at $12.50 per share. Complete Genomics has granted the underwriters a 30-day option to purchase up to 825,000 additional shares at the public offering price, less the underwriting discounts and commissions, to cover over-allotments, if any. All of the shares in the offering are being offered by Complete Genomics.
